Hepatitis C Information Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

Hep C information
Free Newsletter
Hepatitis C Newsletter
We value your privacy. We will not rent your email to anyone.
HEPATITIS NEWS
The top stories compiled from over 5,500 sources, updated every 15 minutes

Cigarette Smoking, Hepatitis C Virus Synergistic in Raising Liver Cancer Risk
Extract not available.

Potential role of lycopene in the treatment of hepatitis C and prevention of hepatocellular carcinoma
Today's Oncology News: Pallidin & Breast Cancer Metastasis D Scott Cunningham MD, PhD, MDLinx Oncology

Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China
1 Department of Epidemiology, Second Military Medical University, Shanghai, China 2 Department of Acute Infectious Diseases, Center for Disease Control and Prevention, Shanghai, China 3 Department of Infectious Diseases, The 1st Affiliated Hospital,

UPDATES AND COMMENTARY RSS Feed

Who Will Respond to Hepatitis C Treatment
The relatively new field of proteomics may be able to predict who will respond to Hepatitis C therapy - before treatment even begins....

Antivirals Combined Without Interferon: New Trial
Three companies unite to begin an innovative Hepatitis C trial, where two oral antiviral drugs will be combined in the absence of interferon....

HCV May Be Able to Be Cleared from Both Blood and Liver
Viral clearance doubled in a Hepatitis C Phase II trial during standard therapy when coupled with GlobeImmune's GI-5005. Because Hepatitis C must be eradicated not just from the blood, but also the liver, GI-5005's ability to speed the clearance rate...

Hepatitis B Core Antibody General Clinical Tests

Test Name
Method
Hepatitis B Core Antibody (HBc, Total Anti- HBc, IgM-anti- HBc Total (IgG+IgM) Anti-HBc

Anti-µ capture

Specimen
Requirements
Serum
Stable for 7 d at RT and indefinitely at 4° C or - 20°C.
Ref. Range
Conventional
International Recommended Units
Negative
Chemical Interfaces
In Vivo Effects
None Found
Diagnostic Information Hepatitis B core protein forms the capsid of the virus and is a potent immunogen. The anti-HBc assay is the most important serological test to document Hepatitis B infection and can be postitive in the face of a Negative HBsAg. A positive total (IgG+IgM) anti-HBc, as performed by the current commercial qualitative assays, is only positive to document acute Hepatitis B.
Remarks Low levels of IgM-anti-HBc can sometimes be present in chronic Hepatitis B and can confuse the diagnosis. In these cases it is necessary to retest patients after several months (or years) to differentiate acute fromchronic infection.


References:
Clinical Guide to Laboratory Tests, third edition.

  Hep C information

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.

©1994-2008 Hepatitis-Central.com
Updated 20 Nov 2008